AVDL AVADEL PHARMACEUTICALS PLC US FDA Inspections 8-K Filing 2023 - FDA Approval Amendment Avadel Pharmaceuticals submitted an amendment to FDA for final approval of LUMRYZ for narcolepsy treatment, following Jazz Pharmaceuticals' request for delisting of a patent.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC